Acute-Phase Protein α1-Antitrypsin—A Novel Regulator of Angiopoietin-like Protein 4 Transcription and Secretion
Open Access
- 1 June 2014
- journal article
- research article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 192 (11), 5354-5362
- https://doi.org/10.4049/jimmunol.1400378
Abstract
The angiopoietin-like protein 4 (angptl4, also known as peroxisome proliferator–activated receptor [PPAR]γ–induced angiopoietin-related protein) is a multifunctional protein associated with acute-phase response. The mechanisms accounting for the increase in angptl4 expression are largely unknown. This study shows that human α1-antitrypsin (A1AT) upregulates expression and release of angplt4 in human blood adherent mononuclear cells and in primary human lung microvascular endothelial cells in a concentration- and time-dependent manner. Mononuclear cells treated for 1 h with A1AT (from 0.1 to 4 mg/ml) increased mRNA of angptl4 from 2- to 174-fold, respectively, relative to controls. In endothelial cells, the maximal effect on angptl4 expression was achieved at 8 h with 2 mg/ml A1AT (11-fold induction versus controls). In 10 emphysema patients receiving A1AT therapy (Prolastin), plasma angptl4 levels were higher relative to patients without therapy (nanograms per milliliter, mean [95% confidence interval] 127.1 [99.5–154.6] versus 76.8 [54.8–98.8], respectively, p = 0.045) and correlated with A1AT levels. The effect of A1AT on angptl4 expression was significantly diminished in cells pretreated with a specific inhibitor of ERK1/2 activation (UO126), irreversible and selective PPARγ antagonist (GW9662), or genistein, a ligand for PPARγ. GW9662 did not alter the ability of A1AT to induce ERK1/2 phosphorylation, suggesting that PPARγ is a critical mediator in the A1AT-driven angptl4 expression. In contrast, the forced accumulation of HIF-1α, an upregulator of angptl4 expression, enhanced the effect of A1AT. Thus, acute-phase protein A1AT is a physiological regulator of angptl4, another acute-phase protein.Keywords
This publication has 56 references indexed in Scilit:
- Angptl4 Protects against Severe Proinflammatory Effects of Saturated Fat by Inhibiting Fatty Acid Uptake into Mesenteric Lymph Node MacrophagesCell Metabolism, 2010
- Angiopoietin-like 4 Interacts with Matrix Proteins to Modulate Wound Healing*Online Journal of Public Health Informatics, 2010
- Reverse crosstalk of TGFβ and PPARβ/δ signaling identified by transcriptional profilingNucleic Acids Research, 2010
- Transcriptional Profiling Identifies Functional Interactions of TGFβ and PPARβ/δ SignalingOnline Journal of Public Health Informatics, 2010
- Induction of ANGPTL4 expression in human airway smooth muscle cells by PMA through activation of PKC and MAPK pathwaysExperimental Cell Research, 2010
- Angiopoietin-like 4 (ANGPTL4, Fasting-induced Adipose Factor) Is a Direct Glucocorticoid Receptor Target and Participates in Glucocorticoid-regulated Triglyceride MetabolismOnline Journal of Public Health Informatics, 2009
- A Highly Conserved Motif within the NH2-terminal Coiled-coil Domain of Angiopoietin-like Protein 4 Confers Its Inhibitory Effects on Lipoprotein Lipase by Disrupting the Enzyme DimerizationOnline Journal of Public Health Informatics, 2009
- Longitudinal Changes in Triglycerides According to ANGPTL4[E40K] Genotype and Longitudinal Body Weight Change in the Atherosclerosis Risk in Communities StudyAnnals of Epidemiology, 2008
- Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasivenessProceedings of the National Academy of Sciences of the United States of America, 2006
- Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissueProceedings of the National Academy of Sciences of the United States of America, 2006